Login
Products
Login
Home
Alerts
Search
Watchlists
Products

Oriental Aromatics Ltd

OAL
NSE
245.13
0.13%
Last Updated:
02 Apr '26, 3:59 PM
Company Overview
Alert
Watchlist
Note

Oriental Aromatics Ltd

OAL
NSE
245.13
0.13%
02 Apr '26, 3:59 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
825Cr
Close
Close Price
245.13
Industry
Industry
Chemicals - Organic
PE
Price To Earnings
1,114.23
PS
Price To Sales
0.82
Revenue
Revenue
1,002Cr
Rev Gr TTM
Revenue Growth TTM
12.34%
PAT Gr TTM
PAT Growth TTM
-98.28%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
195196227197216216237223253226271252
Growth YoY
Revenue Growth YoY%
-3.7-16.22.8-1.010.810.34.412.816.94.514.613.0
Expenses
ExpensesCr
186195216183196194208200234207254238
Operating Profit
Operating ProfitCr
9111142122292319181713
OPM
OPM%
4.70.54.87.29.710.312.110.17.68.06.45.3
Other Income
Other IncomeCr
113222200032
Interest Expense
Interest ExpenseCr
3557346698109
Depreciation
DepreciationCr
555555567888
PBT
PBTCr
2-83414151910433-2
Tax
TaxCr
1-21244432220
PAT
PATCr
1-6231011157111-2
Growth YoY
PAT Growth YoY%
-88.7-171.9-61.8-31.3750.4281.5510.7173.6-86.0-95.5-95.0-126.9
NPM
NPM%
0.6-3.11.11.34.75.16.23.20.60.20.3-0.8
EPS
EPS
0.3-1.80.70.83.03.34.42.10.40.10.2-0.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
4585067557607098698498369281,002
Growth
Revenue Growth%
10.649.10.7-6.722.6-2.3-1.511.07.9
Expenses
ExpensesCr
401441640633554776795789835934
Operating Profit
Operating ProfitCr
57651151271559354479368
OPM
OPM%
12.412.815.216.721.910.76.45.610.16.8
Other Income
Other IncomeCr
70-17246736
Interest Expense
Interest ExpenseCr
5713122413202536
Depreciation
DepreciationCr
14151819171719202431
PBT
PBTCr
444383103137762714487
Tax
TaxCr
16182617352385136
PAT
PATCr
2825578610253209341
Growth
PAT Growth%
-10.4128.750.818.3-47.7-63.0-53.9277.1-97.8
NPM
NPM%
6.14.97.611.314.46.12.31.13.70.1
EPS
EPS
8.31.917.725.630.316.15.92.710.20.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
581717171717171717
Reserves
ReservesCr
308329375447540588608616646645
Current Liabilities
Current LiabilitiesCr
106186233114158186298278375436
Non Current Liabilities
Non Current LiabilitiesCr
684948302974638410795
Total Liabilities
Total LiabilitiesCr
4905736736087458659869951,1451,193
Current Assets
Current AssetsCr
258317420363477555639518632690
Non Current Assets
Non Current AssetsCr
232256253246268310347477513503
Total Assets
Total AssetsCr
4905736736087458659869951,1451,193

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
16-2318117-1-22142-34
Investing Cash Flow
Investing Cash FlowCr
-31-12-10-35-59-46-99-87
Financing Cash Flow
Financing Cash FlowCr
1536-159165178-48121
Net Cash Flow
Net Cash FlowCr
0012-2-99-50
Free Cash Flow
Free Cash FlowCr
-15-36171-18-60-6943-121
CFO To PAT
CFO To PAT%
64.2-41.0209.917.0-1.5-113.01,557.6-99.9
CFO To EBITDA
CFO To EBITDA%
24.8-20.4142.211.2-0.9-41.1302.1-36.7

Ratios

Consolidated
Standalone
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3737327644511,9752,3751,1841,006928
Price To Earnings
Price To Earnings
13.429.313.45.219.444.559.9110.327.0
Price To Sales
Price To Sales
0.81.41.00.62.82.71.41.21.0
Price To Book
Price To Book
1.22.21.91.03.53.91.91.61.4
EV To EBITDA
EV To EBITDA
8.313.18.13.713.127.125.825.613.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
35.335.334.137.244.334.132.131.739.7
OPM
OPM%
12.412.815.216.721.910.76.45.610.1
NPM
NPM%
6.14.97.611.314.46.12.31.13.7
ROCE
ROCE%
11.810.917.022.621.910.74.74.17.2
ROE
ROE%
8.97.414.618.618.38.83.21.45.2
ROA
ROA%
5.74.48.514.213.76.22.00.93.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
#### **Company Overview** **Oriental Aromatics Ltd (OAL)** is one of India’s oldest and largest integrated manufacturers in the **Flavours & Fragrances (F&F)** and **Aroma Chemicals** industry, with over **seven decades** of experience—dating back to its founding in **1955** by **Mr. Keshavlal V. Bodani**. The company operates across three core verticals: 1. **Camphor & Terpene Chemicals** 2. **Specialty Aroma Ingredients (Aroma Chemicals)** 3. **Flavours & Fragrances** OAL is among the **few fully integrated global players**, offering **end-to-end capabilities** from concept and R&D to manufacturing of aroma ingredients, fragrances, and flavours. The company is publicly listed and has evolved from a fragrance distributor into a leading global supplier with a vertically integrated model. --- #### **Business Segments & Key Operations** ##### **1. Camphor & Terpene Chemicals** - **Core Products**: Synthetic camphor (including pharmaceutical-grade and religious grades), terpineol, pine oils, isobornyl acetate, terpene resins. - **Applications**: Religious (puja), topical analgesics (pain relief), pharmaceuticals, industrial, and FMCG. - **Brands**: - **Saraswati Camphor** (established 1967): Dominant in traditional religious segment. - **3 Pine Camphor** (including Bhimseni, launched 1994): Targets urban, wellness-focused consumers; market leader in Gujarat & Maharashtra. - **Manufacturing**: - **Bareilly Plant (Uttar Pradesh)**: - India’s first synthetic camphor plant, established in **1964** with **DuPont technology**. - Production capacity: **7,900 MTPA** of pine-based chemicals and camphor. - **USFDA and WHO-GMP certified**—one of the few global facilities producing pharmaceutical-grade camphor. - **Strategic Highlights**: - **Internalized legacy brands (FY 2024–25)**: OAL now fully owns, manufactures, and markets Saraswati and 3 Pine, which together account for **over 60%** of its powdered camphor production. - **Domestic dominance**: Strong brand presence across India, especially in North India, Punjab, and Rajasthan. - **China Import Mitigation**: Domestic synthetic camphor is **more suitable for puja** than imported natural camphor from China, which requires additional processing. - **Pricing Challenge**: Excess domestic capacity—not Chinese imports—is the primary source of pricing pressure. OAL has adopted **supply discipline** to stabilize pricing. - **Differentiated Moats**: - Domestic **spiritual segment** (resilient demand). - **Global pharmaceutical** use (value-added, regulated market). ##### **2. Specialty Aroma Ingredients (Aroma Chemicals)** - **Core Offerings**: Musk derivatives (e.g., Astromusk), sandalwood alternatives (e.g., Mysornol), Evermoss AB20018, pinene derivatives, esters, and specialty terpenes. - **Scale**: Produces **over 150 specialty aroma ingredients** using **28+ advanced chemical processes**. - **Manufacturing & Expansion**: - **Vadodara, Gujarat**: - **6,200 MTPA** of aroma chemicals; **75% exported**. - Hosts new **multi-product hydrogenation plant** (commissioned July 2024). - **Mahad, Maharashtra**: - **250 MTPA** greenfield plant for **Evermoss**, commissioned Nov 2024. - Fully operational and receiving positive global client feedback. - **Key Strengths**: - **Backward Integration**: Supplies its own flavours & fragrances division and global F&F majors like **IFF, Givaudan, and Symrise**. - **Innovation Focus**: Targets **high-value, low-volume specialty chemicals** with unique IP and process advantages. - **Sustainability**: Offers biodegradable, green chemistry-based solutions (e.g., Evermoss). - **Global Leadership**: One of the few **independent, non-aligned** global aroma chemical suppliers. - **New Product Pipeline**: Targets 33%+ global market share in select molecules (e.g., sandalwood, musk). ##### **3. Flavours & Fragrances (F&F)** - **Applications**: Personal care (shampoos, soaps), home care (detergents, air fresheners), fine fragrances, incense, candles, beverages, dairy, confectionery, instant foods, oral hygiene. - **Clients**: Major **FMCG brands** in India, Southeast Asia, Middle East, Africa, and North/South America. - **Manufacturing**: - **Ambernath, Maharashtra**: - **6,000 MTPA** state-of-the-art facility (since 2014) for fragrances and flavours. - Features integrated R&D, creative formulation, and quality assurance. - **Growth Drivers**: - **Premiumization and rural FMCG penetration** in India. - **Winning Launches**: Achieved **2,534 successful fragrance formulations** in FY 2022–23. - **New Business Wins**: Secured contracts ahead of festive demand, increased wallet share in home care, personal care, and puja product categories. - **Custom Innovation**: Develops award-winning, performance-driven scents using in-house perfumers and deep consumer insights. --- #### **Strategic Positioning & Competitive Advantages** | **Key Strength** | **Details** | |------------------|-----------| | **Vertical Integration** | Full control from R&D to commercial delivery ensures **quality, cost control, and supply security** during global disruptions. | | **Backward Integration** | Internal production of aroma chemicals reduces raw material volatility exposure. ~60% of camphor is internally consumed. | | **Global Expansion** | Supplies **2,000+ customers across 30+ countries**, with strong presence in Asia, Middle East, Europe, and Americas. | | **Sustainability & Innovation** | Uses renewable feedstocks (e.g., alpha-pinene from replanted forests); implements **zero liquid discharge**, biomass boilers, green chemistry. | | **R&D Capabilities** | Two **DSIR-recognized** centers in **Chandivali (Mumbai)** and **Vadodara**, with **40+ research associates**. Developed **100+ commercial aroma ingredients** using 26–28 chemistries. | | **New Facilities Driving Growth** | - **Vadodara Hydrogenation Plant** (multi-product, 700 MTPA): Commissioned July 2024, now contributing to profitability. <br> - **Mahad Evermoss Plant** (single-product, 250 MTPA): Operational since Nov 2024. | | **Strategic Capex Plan** | Investment of **₹3,500–4,000 crores over 3–5 years**, focused on Mahad and Vadodara expansions. Targets **1.7x revenue return** on capital. | --- #### **Financial & Operational Highlights (FY 2024–25)** - **Revenue Mix**: - ~33% from **camphor & terpene chemicals** - ~33% from **specialty aroma ingredients** - ~33% from **flavours & fragrances** - **Performance**: - **12.9% YoY increase** in production volume - **4.8% increase** in sales volume - **11% rise** in operating income - **10.79% growth** in EBITDA - **Global Recognition**: Received **P&G’s Global Supplier Excellence Award 2023** (top 80 out of 60,000 suppliers). --- #### **Challenges & Risk Mitigation** - **Pricing Pressures**: - Commodity aroma chemicals face oversupply; countered by **shifting to high-value specialty products**. - Maintained **disciplined supply** in camphor to avoid price erosion. - **Raw Material Volatility**: - **Alpha-pinene** accounts for ~60% of sales—exposure to price swings. - Mitigated via **diversified sourcing** (no single supplier >10% of requirement) and de-risked procurement. - **Geopolitical & Trade Risks**: - Actively **hedges forex** and monitors trade policies; benefits from “**China+1**” diversification trends. - **Working Capital Intensity**: Extended inventory and debtor days in F&F segment managed via operational efficiency and supply chain optimization. - **Rising Indian Rupee**: In past, caused margin pressure due to imported raw materials; addressed by **price pass-through mechanisms** and cost leadership. --- #### **Recent Developments (2024–25)** - **Internalization of Brands**: Took full control of **Saraswati and 3 Pine**, enhancing margin capture and brand control. - **Expansion Projects Completed**: - Hydrogenation plant (Vadodara) - Evermoss plant (Mahad) - New 250 MTPA unit at Ambernath (subsidary) - **R&D & Innovation**: - 15+ new products in pipeline. - Evermoss adoption by global customers signals **sustainable product leadership**. - **Export Growth**: Rising demand for **specialty terpenes and generic chemicals** due to global supply chain diversification. --- #### **Management & Leadership** - **Mr. Dharmil A. Bodani**, **Chairman & Managing Director**, leads strategy, innovation, and chemical division. Represents **third-generation leadership** of the Bodani family. - **Strategic Vision**: Focus on **global leadership in specialty aroma chemicals**, expanding into **high-margin, niche markets**, and building a **sustainable, integrated F&F powerhouse**.